The weekly litigation news digest is live. Subscribe now

IP Verse

Cyclodextrin - EP3022231

The patent EP3022231 was granted to Curadev Pharma PVT on Apr 18, 2018. The application was filed on Jul 16, 2014 under application number EP14742322A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3022231

CURADEV PHARMA PVT
Application Number
EP14742322A
Filing Date
Jul 16, 2014
Status
Granted And Under Opposition
Mar 16, 2018
Publication Date
Apr 18, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
LIGAND PHARMACEUTICALS INCORPORATEDJan 18, 2019HARRIS -

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTEP1950227
INTERNATIONAL-SEARCH-REPORTUS2009270348
INTERNATIONAL-SEARCH-REPORTWO2013123254
OPPOSITIONEP1950227
OPPOSITIONUS2009270348
OPPOSITIONUS2013303465
OPPOSITIONUS5134127
OPPOSITIONWO03092590
OPPOSITIONWO2013123254

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents